Venturing into the Field of Nuclear Medicine! Taipower and Primo Biotechnology Sign Cooperative MOU Promoting Nuclear Medicine Radiation Safety

July 4, 2025 – Since its establishment in 1975, Taipower Radiation Laboratory has been Taiwan's "Guardian of Nuclear Safety". For half a century, the Laboratory has been charged with monitoring the radiation levels of nuclear power plant facilities, the environment, and personnel. Even following the decommissioning of nuclear reactors, it has remained vigilant. In recent years, the Radiation Laboratory has diversified, successfully achieving certification as a food radiation testing organization. Now, the Laboratory is also venturing into the field of nuclear medicine for the first time. Today, Taipower signed a memorandum of understanding (MOU) with Primo Biotechnology, a domestic pioneer in radiopharmaceuticals for nuclear medicine. The goal is to assist hospitals and clinics in establishing "nuclear power plant-grade" radiation protection monitoring and safety evaluation mechanisms.
This morning, Taipower joined hands with Primo Biotechnology to sign an MOU jointly promoting "radiation protection monitoring and radiation safety operations at medical institutions". Hsu Yung-Hui, vice president of Taipower and CEO of the Nuclear Power Division, and Ya-Yao Huang, CEO of Primo Biotechnology, were on site to sign on behalf of their companies.
A Taipower representative expressed that the Radiation Laboratory serves as a base for Taiwan's radiation protection experts and nuclear technology. The Laboratory is responsible for assessing the radiation doses of nuclear power plant personnel, monitoring environmental radiation, calibrating and maintaining radiation instruments, and conducting radiochemical analysis. In 1997, it became the first radiation testing organization to receive Taiwan Accreditation Foundation (TAF) accreditation. In recent years, the Radiation Laboratory has actively promoted transformation; in 2017, it received the first food radiation testing certification issued by the Ministry of Health and Welfare, and it collaborated with internationally renowned testing institution SGS Taiwan to conduct food radiation testing. In 2019, the Radiation Laboratory also obtained the Ministry of the Interior's Green Building Material certification and the Nuclear Safety Commission's radiation protection monitoring certification, totaling four major national level certifications to date. The Laboratory's testing efforts in diverse sectors such as building materials, cosmetics, and agricultural traceability ensure radiation safety for the populace in their daily lives.

To continuously promote the diverse application of specialized techniques, Taipower is now venturing into the field of nuclear medicine for the first time. Primo Biotechnology is a domestic pioneer in the research and development of radiopharmaceuticals for nuclear medicine, which have applications in cancer diagnosis and treatment. In response to the growing demand for these products, every major hospital in Taiwan must improve their radiation safety evaluation programs-only then can they apply for a pharmaceutical storage and usage license from the Nuclear Safety Commission. The signing of this MOU will facilitate an exchange of radiation protection specialists between Taipower and Primo Biotechnology, and in the future, both parties hope to collaboratively assist medical institutions in establishing more comprehensive radiation protection monitoring and safety assessment mechanisms.
This collaboration is distinct from the Laboratory's previous work, which focused on techniques for testing and calibrating actual samples and instruments. It will instead establish radiation dose evaluation techniques for nuclear medicine settings and provide optimized radiation protection strategies. Whereas the Radiation Laboratory's work at nuclear power plants involved the formulation of precise monitoring mechanisms for all facets-from facilities to personnel-applications in the field of nuclear medicine include the shipment and storage of pharmaceuticals, as well as their usage by relevant personnel, to ensure that medical institutions comply with the highest standards for radiation safety evaluation.
Spokesperson: Vice President Tsai Chih-Meng
Phone: (02) 2366-6271; 0958-749-333
E-mail: u910707@taipower.com.tw
Contact Person: Liao Jui-Ying, director of the Taipower Radiation Laboratory
Phone: (02) 2638-1397; 0910-042-767
E-mail: u808663@taipower.com.tw